Diphenhydramine for the prevention of akathisia induced by prochlorperazine: A randomized, controlled trial

Annals of Emergency Medicine

Volumn 37, Issue 2, 2001, Pages 125-131

  Vinson, David R ^a   Drotts, Daniel L ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; PLACEBO; PROCHLORPERAZINE;

ADJUVANT THERAPY; AKATHISIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMERGENCY WARD; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; SEDATION; VOMITING;

EID: 0035136383     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2001.113032     Document Type: Article

References (45)

1. Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: A randomized, double-blind clinical trial
2. Efficacy of ondansetron and prochlorperazine for the prevention of postoperative nausea and vomiting after total hip replacement or total knee replacement procedures: A randomized, double-blind comparative trial
3. Antiemetic efficacy of high dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting
4. Migraine: Pharmacotherapy in the emergency department
5. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches
6. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache
7. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache
8. Antipsychotic agents: A clinical update
9. Antiemetic-induced akathisia in cancer patients receiving chemotherapy
10. Prochlorperazine induces akathisia in emergency patients
11. Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine
12. Preliminary studies of the pharmacokinetics and pharmacodynamics of prochlorperazine in healthy volunteers
13. The syndrome of motor restlessness - A treatable but unrecognized disorder
14. Drug-induced akathisia revisited
15. Akathisia: A comprehensive review and treatment summary
16. The present state of akathisia
17. Extrapyramidal syndromes in neuroleptictreated patients: Prevalence, risk factors, and association with tardive dyskinesia
18. The epidemiology of drug-induced akathisia. Part I. Acute akathisia
19. A medical student's experience with akathisia
20. Clinical pharmacology of prochlorperazine in healthy young males
21. Akathisia and anesthesia: Refusal of surgery after the administration of metoclopramide
22. An unusual reaction to preoperative medication
23. Management of acute extrapyramidal effects induced by antipsychotic drugs
24. Prophylactic antiparkison drug use. I. Initial prophylaxis and prevention of extrapyramidal side effects
25. A rating scale for acute drug-induced akathisia: Development, reliability, and validity
26. Slow infusion for the reduction of akathisia induced by prochlorperazine: A randomized controlled trial
27. Clinical nonrecognition of neuroleptic-induced movement disorders: A cautionary study
28. Response to antipsychotic medication: The doctor's and consumer's view
29. Akathisia: An overlooked, distressing, but treatable condition
30. In reply: Akathisia and prochlorperazine
31. The pharmacologic treatment of neuroleptic-induced akathisia
32. Akathisia with haloperidol and thiothixene
33. 1-receptor antagonists
34. Paradoxic excitation with diphenhydramine in an adult
35. A randomized, double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy
36. Metoclopramide: Dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy
37. High doses of prochtorperazine for cisplatin-induced emesis: A prospective, random, dose-response study
38. Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin
39. 1 receptor antagonists
40. Clinical significance of reported changes in pain severity
41. Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain?
42. An assessment of clinical wound evaluation scales
43. Do quantitative changes in pain intensity correlate with pain relief and satisfaction?
44. The role of antihistamine therapy in vascular headaches